Intensity Therapeutics, Inc. INTS 深 滬
等待開盤 09-09 09:30:00 美东时间
0.2911
+0.009
+3.19%
華盛通- 最 高0.2978
- 今 開0.29
- 成交量 252.85万股
- 最 低 0.273
- 昨 收 0.2821
- 總市值 729.88万
- 52周最高 4.25
- 市盈率 靜 --
- 換手率 10.08%
- 52周最低 0.1853
- 委 比 98.89%
- 總股本 2507.32万
- 歷史最高 11.44
- 量 比 0.92
- 振 幅 8.79%
- 歷史最低 0.1853
- 每 手 1
- 風險率 1.23%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Benchmark Maintains Speculative Buy on Intensity Therapeutics, Lowers Price Target to $1.5
Benchmark analyst Robert Wasserman maintains Intensity Therapeutics (NASDAQ:INTS) with a Speculative Buy and lowers the price target from $4 to $1.5.
08-20 20:59
Intensity Therapeutics Reports Reduced Losses and Clinical Progress
Intensity Therapeutics, Inc. ( ($INTS) ) has released its Q2 earnings. Here is ...
08-14 12:23
美股机会日报丨贝森特称九月或降息50个基点；中国资产爆发！网易盘前涨超5%，阿里巴巴盘前涨超3%
贝森特称九月或降息50个基点；中国资产爆发！网易盘前涨超5%，阿里巴巴盘前涨超3%；马斯克：特斯拉Robotaxi9月将向公众开放>>
08-13 21:03
美股大行评级 | 潜在涨幅921.1%！Intensity Therapeutics获Brookline Capital升级至"买入"，目标价上调至3美元
今日重点评级关注：Brookline Capital：上调Intensity Therapeutics评级至"买入"，目标价3美元；Chardan Capital：维持Taysha Gene Therapies"买入"评级，目标价从9美元升至10美元
08-13 09:10
Intensity Therapeutics Amends Bylaws for Quorum Change
The latest update is out from Intensity Therapeutics, Inc. ( ($INTS) ). On Augu...
08-13 05:15
Brookline Capital Upgrades Intensity Therapeutics to Buy, Announces $3 Price Target
Brookline Capital analyst Kumaraguru Raja upgrades Intensity Therapeutics (NASDAQ:INTS) from Hold to Buy and announces $3 price target.
08-13 05:06
Intensity Therapeutics regains compliance with Nasdaq requirement
Intensity Therapeutics (NASDAQ:INTS) said on Tuesday that the biotechnology company has regained compliance with Nasdaq's minimum stockholders' equity requirement. On August 7, the company filed its q...
08-12 21:13
Intensity Therapeutics Regains Nasdaq Compliance
Intensity Therapeutics, Inc. (NASDAQ:INTS) ("Intensity" or "the Company"), a late-stage clinical biotechnology company focused on the discovery and development of novel intratumoral cancer therapies that are designed to
08-12 19:49
Intensity Therapeutics shares are trading higher after the company reported better-than-expected Q2 EPS results.
Intensity Therapeutics shares are trading higher after the company reported bet...
08-09 00:39
Intensity Therapeutics Q2 EPS $(0.13) Beats $(0.20) Estimate
Intensity Therapeutics (NASDAQ:INTS) reported quarterly losses of $(0.13) per share which beat the analyst consensus estimate of $(0.20) by 34.34 percent. This is a 63.89 percent increase over losses of $(0.36) per share
08-08 05:02
